Cargando…

Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study

Background. Prior receipt of a trivalent seasonal influenza vaccine (TIV) can affect hemagglutination inhibition (HI) antibody responses to pandemic influenza vaccines. We investigated the effect of TIV priming on humoral responses to AS03-adjuvanted and nonadjuvanted A(H1N1)pdm09 vaccines, the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy-Ghanta, Sumita, Van der Most, Robbert, Li, Ping, Vaughn, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195439/ https://www.ncbi.nlm.nih.gov/pubmed/24864125 http://dx.doi.org/10.1093/infdis/jiu284

Ejemplares similares

Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
por: Gefenaite, Giedre, et al.
Publicado: (2013)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals
por: Strengell, Mari, et al.
Publicado: (2012)

535 Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network
por: Flannery, Brendan, et al.
Publicado: (2014)

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials
por: van der Most, Robbert G., et al.
Publicado: (2017)

No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
por: Mahmud, Salaheddin M., et al.
Publicado: (2012)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial()
por: Yang, William H., et al.
Publicado: (2013)

Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis
por: Venkatesan, Sudhir, et al.
Publicado: (2017)

Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation
por: Sominina, Anna, et al.
Publicado: (2023)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
por: Friel, Damien, et al.
Publicado: (2020)

Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination
por: Huijskens, Elisabeth G. W., et al.
Publicado: (2013)

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2022)

Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016)

Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons
por: Monamele, Chavely Gwladys, et al.
Publicado: (2019)

Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis
por: Okoli, George N, et al.
Publicado: (2021)

Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years
por: McGovern, Ian, et al.
Publicado: (2023)

Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People
por: Minchole, Elisa, et al.
Publicado: (2016)

Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines
por: Ambrose, Christopher S, et al.
Publicado: (2016)

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series
por: Wijnans, Leonoor, et al.
Publicado: (2017)

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
por: Kissling, Esther, et al.
Publicado: (2019)

Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study
por: Trieu, Mai-Chi, et al.
Publicado: (2019)

Use of Biolayer Interferometry to Identify Dominant Binding Epitopes of Influenza Hemagglutinin Protein of A(H1N1)pdm09 in the Antibody Response to 2010–2011 Influenza Seasonal Vaccine
por: Guo, Zhu, et al.
Publicado: (2023)

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
por: Lefevre, Eric A., et al.
Publicado: (2012)

Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?
por: Penttinen, Pasi M, et al.
Publicado: (2016)

Estimating the burden of A(H1N1)pdm09 influenza in Finland during two seasons
por: SHUBIN, M., et al.
Publicado: (2014)

Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons
por: Casado, Itziar, et al.
Publicado: (2014)

Experimental H1N1pdm09 infection in pigs mimics human seasonal influenza infections
por: Schwaiger, Theresa, et al.
Publicado: (2019)

Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
por: Cao, Jia-Qian, et al.
Publicado: (2020)

Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season
por: Boikos, Constantina, et al.
Publicado: (2021)

Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009
por: Mörner, Andreas, et al.
Publicado: (2012)

Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns
por: Helmig, Rikke B., et al.
Publicado: (2015)

A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019–2020 Influenza Season in the United States
por: Divino, Victoria, et al.
Publicado: (2021)

Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season
por: Ando, Soichiro
Publicado: (2019)

Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort( )
por: Hoa, Le Nguyen Minh, et al.
Publicado: (2020)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nek6v1etn7vj4h10ed5nof4m4m